Drugs

Are There Potential Non-Lipid-Lowering Uses of Statins?
pp. 517-522(6)
Author: Wheeler D.C.

Ergot Alkaloids: Current Status and Review of Clinical Pharmacology and Therapeutic Use Compared with Other Oxytocics in Obstetrics and Gynaecology
pp. 523-535(13)
Authors: N.J.A. de Groot A.; van Dongen P.W.J.; Vree T.B.; Hekster Y.A.; van Roosmalen J.

New Approaches to Influenza Chemotherapy: Neuraminidase Inhibitors
pp. 537-553(17)
Authors: Calfee D.P.; Hayden F.G.

Choosing Drug Therapy for Multiple Sclerosis: An Update
pp. 555-569(15)
Authors: van Oosten B.W.; Truyen L.; Barkhof F.; Polman C.H.

Recommended Drug Treatment Strategies for the Alcoholic Patient
pp. 571-585(15)
Authors: Schaffer A.; Naranjo C.A.

Urinary Incontinence in the Elderly: Drug Treatment Options
pp. 587-595(9)
Authors: Chutka D.S.; Takahashi P.Y.

Wilms' Tumour: Optimal Treatment Strategies
pp. 597-605(9)
Authors: Suryanarayan K.; Marina N.

Rifapentine
pp. 607-616(10)
Authors: Jarvis B.; Lamb H.M.

Rifapentine: A Viewpoint by C.M. Tam
pp. 617-617(1)
Author: Tan C.M.

Rifapentine: A Viewpoint by Pierre Chaulet
pp. 617-617(1)
Author: Chaulet P.

Edrecolomab (Monoclonal Antibody 17-1A)
pp. 619-626(8)
Authors: Adkins J.C.; Spencer C.M.

Edrecolomab (Monoclonal Antibody 17-1A): A Viewpoint by Harry Bleiberg
pp. 627-628(2)
Author: Bleiberg H.

Edrecolomab (Monoclonal Antibody 17-1A): A Viewpoint by John Zalcberg
pp. 627-628(2)
Author: Zalcberg J.

Abciximab: An Updated Review of its Use in Ischaemic Heart Disease
pp. 629-665(37)
Authors: Foster R.H.; Wiseman L.R.

5-Methoxypsoralen: A Review of its Effects in Psoriasis and Vitiligo
pp. 667-690(24)
Authors: McNeely W.; Goa K.L.

Mexiletine: A Review of its Therapeutic Use in Painful Diabetic Neuropathy
pp. 691-707(17)
Authors: Jarvis B.; Coukell A.J.

Topotecan: A Review of its Potential in Advanced Ovarian Cancer
pp. 709-723(15)
Authors: Brogden R.N.; Wiseman L.R.

Mometasone Furoate: A Review of its Intranasal Use in Allergic Rhinitis
pp. 725-745(21)
Authors: Onrust S.V.; Lamb H.M.